Multiple sclerosis Trials in Magdeburg, Germany
Conditions / Multiple sclerosis / Magdeburg, Germany
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06220201 | A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) | RECRUITING | PHASE1 |
| NCT07224373 | An Open-label Study of AZD0120 in Adults With Multiple Sclerosis | RECRUITING | — |
| NCT00185211 | BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study | COMPLETED | PHASE3 |
| NCT01166178 | Zoledronic Acid in MS-patients With Osteoporosis | TERMINATED | PHASE3 |
| NCT00662649 | Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT02907281 | Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis | COMPLETED | — |
| NCT01707992 | The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE3 |
| NCT00751881 | An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT06780150 | A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS) | RECRUITING | — |
| NCT02047097 | Dimethyl Fumarate (DMF) Observational Study | COMPLETED | — |